| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 65.92B | 67.29B | 62.13B | 52.89B | 41.85B | 38.67B |
| Gross Profit | 23.13B | 23.73B | 21.80B | 17.83B | 13.90B | 13.35B |
| EBITDA | 8.97B | 9.50B | 8.30B | 5.83B | 3.37B | 3.70B |
| Net Income | 5.35B | 6.00B | 4.97B | 3.33B | 1.91B | 1.96B |
Balance Sheet | ||||||
| Total Assets | 73.38B | 75.85B | 78.23B | 67.18B | 61.92B | 58.61B |
| Cash, Cash Equivalents and Short-Term Investments | 13.56B | 12.77B | 16.80B | 14.30B | 16.16B | 17.30B |
| Total Debt | 73.00M | 1.05B | 5.30B | 712.00M | 958.00M | 1.22B |
| Total Liabilities | 17.93B | 19.15B | 25.52B | 20.00B | 16.33B | 13.62B |
| Stockholders Equity | 55.45B | 56.69B | 52.72B | 46.95B | 45.38B | 44.98B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.26B | 498.00M | 947.00M | 1.34B | 1.33B |
| Operating Cash Flow | 0.00 | 4.45B | 2.74B | 1.92B | 2.02B | 3.04B |
| Investing Cash Flow | 0.00 | -1.15B | -3.78B | -1.06B | -932.00M | -2.03B |
| Financing Cash Flow | 0.00 | -7.25B | 2.80B | -2.90B | -2.83B | -1.50B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥26.12B | 13.32 | ― | 2.89% | 6.15% | 2.98% | |
79 Outperform | ¥98.94B | 15.13 | ― | 3.23% | 7.28% | 4.16% | |
78 Outperform | $757.93B | 18.06 | 11.99% | 0.65% | 8.50% | 14.06% | |
75 Outperform | ¥67.90B | 12.98 | ― | 3.12% | 2.78% | -5.32% | |
75 Outperform | ¥13.30B | 11.72 | ― | 5.39% | 6.45% | 26.58% | |
73 Outperform | ¥18.22B | 18.81 | ― | 2.93% | -1.58% | 12.24% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |